Bleeding disorders associated with trauma are of paramount importance when dealing with the acutely injured individual. Statistically, up to 40% of trauma related deaths are assumed to be related to hemorrhage.1,2 Historically, there have been many varying positions on the way to handle this entity.3–5 Ironically, it is not always the injury but the physiologic sequelae of that injury that lead to trauma associated deaths.6,7 Over time, newer theories have been developed to help the clinician begin to understand the etiology and treatment of this process.6,8,9 The purpose of this paper is to review current literature and explain how these new concepts helped change practice in an urban, academic, Level One Trauma Center.
GreerSERhynhartKKGuptaRCorwinHL. New developments in massive transfusion in trauma. Curr Opin Anaesthesiol. 2010;23:246-250.
2.
HessJRBrohiKDuttonRP. The coagulopathy of trauma: a review of mechanisms. J Trauma. 2008;65:748-754.
3.
HolcombJBJenkinsDRheeP. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307-310.
4.
CosgriffNMooreEESauaiaAKenny-MoynihanMBurchJMGallowayB. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma. 1997;42:857-861.
5.
VaslefSNKnudsenNWNeliganPJSebastianMW. Massive transfusion exceeding 50 units of blood products in trauma patients. J Trauma. 2002;53:291-295.
6.
HessJRLawsonJH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma. 2006;60(6 suppl):S12-S19.
7.
ThorsenKRingdalKGStrandKSøreideEHagemoJSøreideK. Clinical and cellular effects of hypothermia, acidosis and coagulopathy in major injury. Br J Surg. 2011;98:894-907.
8.
ShazBHDenteCJHarrisRSMacLeodJBHillyerCD. Transfusion management of trauma patients. Anesth Analg. 2009;108:1760-1768.
9.
KashukJLMooreEESawyerM. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252:434-442.
10.
KashukJLMooreEESawyerM. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg. 2010;251:604-614.
11.
KashukJLMooreEEWohlauerM. Initial experiences with point-of-care rapid thrombelastography for management of life-threatening postinjury coagulopathy. Transfusion. 2012;52:23-33.
12.
DenteCJShazBHNicholasJM. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center. J Trauma. 2009;66:1616-1624.
13.
SimmonsJWWhiteCERitchieJDHardinMODubickMABlackbourneLH. Mechanism of injury affects acute coagulopathy of trauma in combat casualties. J Trauma. 2011;71(1 suppl):S74-S77.
14.
MillerRD. Massive blood transfusions: the impact of Vietnam military data on modern civilian transfusion medicine. Anesthesiology. 2009;110:1412-1416.
15.
DannEJMichaelsonMBarzelayMHoffmanRBonsteinL. Transfusion medicine during the summer of 2006: lessons learned in northern Israel. Transfus Med Rev. 2008;22:70-76.
16.
SchusterKMDavisKALuiFYMaerzLLKaplanLJ. The status of massive transfusion protocols in United States trauma centers: massive transfusion or massive confusion?Transfusion. 2010;50:1545-1551.
17.
MaloneDLHessJRFingerhutA. Massive transfusion practices around the globe and a suggestion for a common massive transfusion protocol. J Trauma. 2006;60(6 suppl):S91-S96.
18.
RutledgeJXuMSimpsonJ. Application of the Toyota Production System improves core laboratory operations. Am J Clin Pathol. 2010;133:24-31.
19.
KimCSSpahlingerDAKinJMBilliJE. Lean health care: What can hospitals learn from a world-class automaker?J Hosp Med. 2006;1:191-199.
20.
JoostenTBongersIJanssenR. Application of lean thinking to health care: issues and observations. Int J Qual Health Care. 2009;21:341-347.
21.
MeyerH. Life in the “lean” lane: performance improvement at Denver Health. Health Aff (Millwood). 2010;29: 2054-2060.
22.
JohnsonJLMooreEEKashukJL. Effect of blood products transfusion on the development of postinjury multiple organ failure. Arch Surg. 2010;145:973-977.
23.
TieuBHHolcombJBSchreiberMA. Coagulopathy: its pathophysiology and treatment in the injured patient. World J Surg. 2007;31:1055-1064.
24.
KashukJLMooreEEJohnsonJL. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer?J Trauma. 2008;65:261-270.
25.
BrohiKCohenMJGanterMT. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64:1211-1217.
26.
HartertH. Thrombelastography, a method for physical analysis of blood coagulation. Z Gesamte Exp Med. 1951;117:189-203.
27.
GordonPCJamesMFMSpearmanCWMillarAJWKahnD. Decreasing blood product requirements after orthotopic liver transplantation. S Afr J Surg. 2002;40:46-48.
28.
SpaldingGJHartrumpfMSierigTOesbergNKirschkeCGAlbesJM. Cost reduction of perioperative coagulation management in cardiac surgery: value of “bedside” thrombelastography (ROTEM). Eur J Cardiothorac Surg. 2007;31:1052-1057.
29.
McMichaelMASmithSA. Viscoelastic coagulation testing: technology, applications, and limitations. Vet Clin Pathol. 2011;40:140-153.
30.
WohlauerMVMooreEEHarrJGonzalezEFragosoMSillimanCC. A standardized technique for performing thromboelastography in rodents. Shock. 2011;36: 524-526.
31.
GottumukkalaVNSharmaSKPhilipJ. Assessing platelet and fibrinogen contribution to clot strength using modified thromboelastography in pregnant women. Anesth Analg. 1999;89:1453-1455.
32.
JegerVZimmermannHExadaktylosAK. Can RapidTEG accelerate the search for coagulopathies in the patient with multiple injuries?J Trauma. 2009;66:1253-1257.
33.
TheusingerOMWannerGAEmmertMY. Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma. Anesth Analg. 2011; 113:1003-1012.
34.
DavenportRKhanS. Management of major trauma haemorrhage: treatment priorities and controversies. Br J Haematol. 2011;155:537-548.
35.
DoranCMWoolleyTMidwinterMJ. Feasibility of using rotational thromboelastometry to assess coagulation status of combat casualties in a deployed setting. J Trauma. 2010;69(suppl 1):S40-S48.
36.
Williams-JohnsonJAMcDonaldAHStrachanGGWilliamsEW. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2). A randomised, placebo-controlled trial. West Indian Med J. 2010;59:612-624.
37.
MorrisonJJDuboseJJRasmussenTEMidwinterMJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) study. Arch Surg. 2012;147:113-119.
38.
MurkinJM. Lessons learned in antifibrinolytic therapy: the BART trial. Semin Cardiothorac Vasc Anesth. 2009;13:127-131.
39.
PentadePeppoAPierriMDScafuriA. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs. Texas Heart Inst J. 1995;22:231-236.
40.
Vander SalmTJAnsellJEOkikeON. The role of epsilon-aminocaproic acid in reducing bleeding after cardiac operation: a double-blind randomized study. J Thorac Cardiovasc Surg. 1988;95:538-540.
41.
ShazBHDenteCJNicholasJ. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion. 2010;50:493-500.
42.
HessJRHolcombJB. Transfusion practice in military trauma. Transfus Med. 2008;18:143-150.
43.
DavenportRCurryNMansonJ. Hemostatic effects of fresh frozen plasma may be maximal at red cell ratios of 1:2. J Trauma. 2011;70:90-95.
44.
CottonBAGunterOLIsbellJ. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma. 2008;64:1177-1182.
45.
JohnsonJWGraciasVHSchwabCW. Evolution in damage control for exsanguinating penetrating abdominal injury. J Trauma. 2001;51:261-269.
46.
MatijevicNWangY-WWKostousovVWadeCEVijayanKVHolcombJB. Decline in platelet microparticles contributes to reduced hemostatic potential of stored plasma. Thromb Res. 2011;128:35-41.
